mucolipidosis II alpha/beta

Summary
Synonym
  • I-cell disease
  • inclusion-cell disease
  • mucolipidosis II
Definition
A mucolipidosis that is characterized by short stature, skeletal abnormalities, cardiomegaly, and developmental delay, caused by a defect in proper lysosomal enzyme phosphorylation and localization, which results in accumulation of lysosomal substrates, and that has_material_basis_in homozygous or compound heterozygous mutation in the GNPTAB gene.
Super Class
mucolipidosis
Disease Ontology
DOID:0080070
Mondo Disease Ontology
OMIM
GARD
MGI genotype (from TogoID)
Related Genes
Displaying 1 entry
Gene ID Gene Symbol Description Source
79158 GNPTAB N-acetylglucosamine-1-phosphate transferase subunits alpha and beta
Displaying 1 entry
Gene ID Gene Symbol Description Source
432486 Gnptab N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits
Displaying 1 entry
Gene ID Gene Symbol Description Source
553365 gnptab N-acetylglucosamine-1-phosphate transferase subunits alpha and beta
Related Glycoprotein
The Human Phenotype Ontology
Displaying entries 71 - 80 of 135 in total
HPO ID HPO Term
HP:0000348 High forehead
HP:0000403 Recurrent otitis media
HP:0000463 Anteverted nares
HP:0000485 Megalocornea
HP:0000767 Pectus excavatum
HP:0000882 Hypoplastic scapulae
HP:0000938 Osteopenia
HP:0001010 Hypopigmentation of the skin
HP:0001048 Cavernous hemangioma
HP:0001171 Split hand
Displaying 1 entry
Gene ID Gene Symbol Description
79158 GNPTAB N-acetylglucosamine-1-phosphate transferase subunits alpha and beta

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024